Neuroblastoma

Neuroblastoma is a malignant (cancerous) tumor that develops from nerve tissue. It usually occurs in infants and children.

Programs + Services


Neuro-Oncology Program

Our Neuro-Oncology Program in downtown Boston, offers the most advanced methods for diagnosing and treating specific benign and malignant tumors of the brain.
More information about programs and services


Gamma Knife Center

Our Gamma Knife Center offers a safe and painless alternative for treating brain cancers, benign tumors, facial pain and vascular malformations. Learn more now.
More information about programs and services

Doctors + Care Team

Adel M. Malek, MD, PhD

Adel M. Malek, MD, PhD

Accepting New Patients

Title(s): Chief, Neurovascular Surgery; Director, Cerebrovascular & Endovascular Division Professor, Tufts University School of Medicine
Department(s): Neurosurgery
Appt. Phone: 617-636-8200
Fax #: 617-636-7587

Aneurysms, arteriovenous malformations, dural fistulas, subarachnoid hemorrhage, intracranial atherosclerosis, arterial dissection

View Full Profile for Adel M. Malek, MD, PhD

John E. Mignano, MD, PhD

John E. Mignano, MD, PhD

Title(s): Radiation Oncologist; Clinic Director; Associate Professor, Tufts University School of Medicine
Department(s): Radiation Oncology, Pediatric Radiation Oncology
Appt. Phone: 617-636-6161
Fax #: 617-636-4513

Oncologic consultation for general radiotherapy and Gamma Knife, pediatric radiation oncology

View Full Profile for John E. Mignano, MD, PhD

Julian K. Wu, MD

Julian K. Wu, MD

Accepting New Patients

Title(s): Associate Chairman, Neurosurgery; Chief, Neurosurgical Oncology; Neurosurgery Residency Program Director; Professor, Tufts University School of Medicine
Department(s): Neurosurgery
Appt. Phone: 617-636-4500
Fax #: 617-636-7587

Neuro-oncology, Gamma Knife radiosurgery, meningiomas, pituitary tumors, gliomas, brain metastasis, trigeminal neuralgia

View Full Profile for Julian K. Wu, MD

Kathryn Huber, MD, PhD

Kathryn Huber, MD, PhD

Accepting New Patients

Title(s): Radiation Oncologist; Assistant Professor, Tufts University School of Medicine
Department(s): Radiation Oncology
Appt. Phone: 617-636-6161
Fax #: 617-636-6131

Radiotherapy for cancers of the lung, gastrointestinal tract, breast and head and neck

View Full Profile for Kathryn Huber, MD, PhD

Suriya Jeyapalan, MD, MPH

Suriya Jeyapalan, MD, MPH

Accepting New Patients

Title(s): Neuro-Oncologist
Department(s): Neurology; Cancer Center
Appt. Phone: 617-636-5848
Fax #:

Neuro-oncology, brain tumors, neurologic metastases

View Full Profile for Suriya Jeyapalan, MD, MPH

Research + Clinical Trials


A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

This partially randomized phase III trial studies iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Crizotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving iobenguane I-131 or crizotinib and standard therapy may work better in treating younger patients with neuroblastoma or ganglioneuroblastoma.
More information about research and clinical trials